Impaired Proliferation of CD8+T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells 2024 Laboratoř imunoterapie Kalkusová K.Táborská P.Stakheev D.Rataj J.Smite S.Darras E.Albo J.Bartůňková J.Vannucci L.Smrž D.Journal of Immunology Research. 2024; 2024); 553794810.1155/2024/5537948
Novel PD-L1- and collagen-expressing patient-derived cell line of undifferentiated pleomorphic sarcoma (JBT19) as a model for cancer immunotherapy. 2023 Laboratoř imunoterapie Táborská P.Lukáč P.Stakheev D.Rajsiglová L.Kalkusová K.Strnadová K.Lacina L.Dvořánková B.Novotný J.Kolář M.Vraná M.Čechová H.Ransdorfová S.Valerianová M.Smetana Jr. K.Vannucci L.Smrž D.Scientific Reports. 2023; 13(November); 1907910.1038/s41598-023-46305-7
The Role of miR-155 in Antitumor Immunity 2022 Laboratoř imunoterapie Kalkusová K.Táborská P.Stakheev D.Smrž D.Cancers (Basel). 2022; 14(21); 541410.3390/cancers14215414
Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors 2022 Laboratoř imunoterapie Kalkusova K.Smite S.Darras E.Táborská P.Stakheev D.Vannucci L.Bartůňková J.Smrž D.International Journal of Molecular Sciences. 2022; 23(19); 1108010.3390/ijms231911080
